SAFE is a major player in formulating and manufacturing special foods and diets for the world of medical research. With over 400 clients (private and public laboratories, well-known private clients, etc.), the company is the market leader in France and generates about 20% of its turnover abroad.
Georges Hasson, Chairman: « We are very pleased to be associated with Capital Croissance and Unigrains in this new stage of our development. Our 5-6 year target is for SAFE to become the undisputed leader in Europe with significant positions in targeted emerging countries, particularly in Asia and Latin America. »